4.4 Article

Relationship Between Cysteinyl-Leukotriene-1 Receptor and Human Transitional Cell Carcinoma in Bladder

Journal

UROLOGY
Volume 73, Issue 4, Pages 916-921

Publisher

ELSEVIER SCIENCE INC
DOI: 10.1016/j.urology.2008.11.005

Keywords

-

Ask authors/readers for more resources

OBJECTIVES To investigate the leukotriene (LT) D-4 (LTD4) receptor (cysteinyl-LT1 receptor [CysLT(1)R]) expression in transitional cell carcinoma (TCC) of the bladder, as well as the effects of the CysLT(1)R antagonist on cell proliferation in TCC cell lines. The metabolism of arachidonic acid by either cyclooxygenase or lipoxygenase is thought to play an important role in carcinogenesis. LTD4 is a pro-inflammatory mediator derived from arachidonic acid through various enzymatic steps, and 5-lipoxygenase is an important factor in generating LTD4. METHODS CysLT(1)R expression in TCC tissue and normal bladder tissue was examined. CysLT(1)R expression was detected using immunohistochemistry. The effects of the CysLT(1)R antagonist on TCC cell growth were examined by 3-(4,5-dimethylthiazol-2-thiazolyl)-2,5-diphenyltetrazolium bromide assay and reverse transcriptase-polymerase chain reaction. Flow cytometry was used to determine whether the CysLT(1)R antagonist induced apoptosis. RESULTS Initially, only slight CysLT(1)R expression was detected in normal bladder tissues and marked CysLT(1)R expression was detected in the TCC tissues. CysLT(1)R expression was greater in high-grade cancer than in low-grade cancer. Furthermore, CysLT(1)R expression was also greater in advanced-stage cancer than in early-stage cancer. Finally, the CysLT(1)R antagonist caused marked inhibition of TCC cells by inducing early apoptosis. CONCLUSIONS CysLT(1)R was induced in TCC. The results suggest that the CysLT(1)R antagonist might mediate potent antiproliferative effects on TCC cells. Thus, the target of the CysLT(1)R is potentially a new therapy in the treatment of TCC. UROLOGY 73: 916-921, 2009. Crown Copyright (C) 2009 Published by Elsevier Inc.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.4
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Rheumatology

Predictive factors for structural remission using abatacept: Results from the ABROAD study

Kosaku Murakami, Masahiro Sekiguchi, Shintaro Hirata, Takao Fujii, Kiyoshi Matsui, Satoshi Morita, Koichiro Ohmura, Yutaka Kawahito, Norihiro Nishimoto, Tsuneyo Mimori, Hajime Sano, K. Maeda, H. Nakahara, S. Higa, Y. Hamano, M. Nishide, S. Nozaki, A. Yamamoto, Y. Kukita, T. Senoo, H. Nagahara, H. Hashimoto, A. Yokota, K. Miki, N. Shinmyo, T. Fujimura, H. Goto, M. Tada, T. Koike, Y. Sugioka, T. Okano, T. Fujimoto, Y. Ozaki, Y. Son, M. Kitano, S. Irimajiri, T. Hidaka, Y. Nozaki, M. Funauchi, S. Hino, M. Sugiyama, T. Shiga, T. Kuroiwa, I. Yoshii, M. Hashimoto, N. Yamakawa, K. Hatta, T. Azuma, T. Igawa, K. Inoue, T. Takeuchi, M. Tanaka, K. Higami, M. Namiki, T. Yamazaki, T. Nakatani, T. Saito, Y. Imura, T. Nakajima, S. Namiuchi, K. Akashi, M. Nakata, T. Takeuchi, A. Omoto, A. Nanpei, S. Watanabe, K. Ushio, Y. Hideki, S. Oshima, S. Kashiwagi, H. Yokoyama, M. Morimoto, Y. Uesugi, S. Mokuda, H. Yanagita, K. Sugimoto, T. Sasaki, A. Hashiramoto

MODERN RHEUMATOLOGY (2019)

Article Rheumatology

Risk factors for cytomegalovirus disease with cytomegalovirus re-activation in patients with rheumatic disease

Shunya Kaneshita, Takashi Kida, Isao Yokota, Hidetake Nagahara, Takahiro Seno, Makoto Wada, Masataka Kohno, Yutaka Kawahito

MODERN RHEUMATOLOGY (2020)

Article Rheumatology

Association between preexisting lung involvements and the risk of diffuse alveolar hemorrhage in patients with microscopic polyangiitis: A multi-center retrospective cohort study

Takashi Kida, Tadashi Tanaka, Isao Yokota, Keiichi Tamagaki, Tomoya Sagawa, Masatoshi Kadoya, Takahiro Yamada, Kazuki Fujioka, Makoto Wada, Masataka Kohno, Noriya Hiraoka, Atsushi Omoto, Wataru Fukuda, Yutaka Kawahito

MODERN RHEUMATOLOGY (2020)

Article Rheumatology

Effectiveness and safety of chronic hepatitis C treatment with direct-acting antivirals in patients with rheumatic diseases: A case-series

Takashi Kida, Atsushi Umemura, Shunya Kaneshita, Risa Sagawa, Takuya Inoue, Shogo Toyama, Makoto Wada, Masataka Kohno, Ryo Oda, Tohru Inaba, Yoshito Itoh, Yutaka Kawahito

MODERN RHEUMATOLOGY (2020)

Review Rheumatology

Efficacy and safety of tacrolimus in patients with rheumatoid arthritis - A systematic review and meta-analysis

Yuko Kaneko, Yutaka Kawahito, Masayo Kojima, Takeo Nakayama, Shintaro Hirata, Mitsumasa Kishimoto, Hirahito Endo, Yohei Seto, Hiromu Ito, Keiichiro Nishida, Isao Matsushita, Toshihisa Kojima, Naoyuki Kamatani, Kiichiro Tsutani, Ataru Igarashi, Mieko Hasegawa, Nobuyuki Miyasaka, Hisashi Yamanaka

Summary: Tacrolimus shows effective outcomes and acceptable safety profile in managing RA patients, significantly improving ACR20 achievement rates with tolerable adverse effects.

MODERN RHEUMATOLOGY (2021)

Article Environmental Sciences

Exposure to particulate matter upregulates ACE2 and TMPRSS2 expression in the murine lung

Tomoya Sagawa, Takahiro Tsujikawa, Akiko Honda, Natsuko Miyasaka, Michitaka Tanaka, Takashi Kida, Koichi Hasegawa, Tomoaki Okuda, Yutaka Kawahito, Hirohisa Takano

Summary: The study used a mouse model exposed to particulate matter to evaluate the increased expression of ACE2 and TMPRSS2 in the lungs, which are required for the entry of SARS-CoV-2. The findings suggest that particulate matter may enhance the expression of these proteins in alveolar type 2 cells and macrophages, potentially making them targets for SARS-CoV-2. This research provides insight into how air pollution could influence the severity of COVID-19 infection.

ENVIRONMENTAL RESEARCH (2021)

Review Rheumatology

Systematic review and meta-analysis of biosimilar for the treatment of rheumatoid arthritis informing the 2020 update of the Japan College of Rheumatology clinical practice guidelines for the management of rheumatoid arthritis

Eiichi Tanaka, Yutaka Kawahito, Masataka Kohno, Shintaro Hirata, Mitsumasa Kishimoto, Yuko Kaneko, Hiroya Tamai, Yohei Seto, Akio Morinobu, Takahiko Sugihara, Atsuko Murashima, Masayo Kojima, Masaaki Mori, Hiromu Ito, Toshihisa Kojima, Yasumori Sobue, Keiichiro Nishida, Isao Matsushita, Takeo Nakayama, Hisashi Yamanaka, Masayoshi Harigai

Summary: The systematic review of 20 randomized controlled trials showed that biosimilars and reference bDMARDs were equally effective and safe for managing rheumatoid arthritis.

MODERN RHEUMATOLOGY (2022)

Article Rheumatology

Systematic review for the treatment of older rheumatoid arthritis patients informing the 2020 update of the Japan College of Rheumatology clinical practice guidelines for the management of rheumatoid arthritis

Takahiko Sugihara, Yutaka Kawahito, Akio Morinobu, Yuko Kaneko, Yohei Seto, Toshihisa Kojima, Hiromu Ito, Masataka Kohno, Takeo Nakayama, Yasumori Sobue, Keiichiro Nishida, Isao Matsushita, Atsuko Murashima, Masaaki Mori, Eiichi Tanaka, Shintaro Hirata, Mitsumasa Kishimoto, Hisashi Yamanaka, Masayo Kojima, Masayoshi Harigai

Summary: This study aims to provide an evidence base for developing CPG for the management of rheumatoid arthritis in older adults, by conducting a systematic literature review and assessing the quality of evidence, yielding conclusions on the efficacy and safety of different drug treatments for older RA patients.

MODERN RHEUMATOLOGY (2022)

Article Rheumatology

Comprehensive risk analysis of postoperative complications in patients with rheumatoid arthritis for the 2020 update of the Japan College of Rheumatology clinical practice guidelines for the management of rheumatoid arthritis

Hiromu Ito, Koichi Murata, Yasumori Sobue, Toshihisa Kojima, Keiichiro Nishida, Isao Matsushita, Yutaka Kawahito, Masayo Kojima, Shintaro Hirata, Yuko Kaneko, Mitsumasa Kishimoto, Masataka Kohno, Masaaki Mori, Akio Morinobu, Atsuko Murashima, Yohei Seto, Takahiko Sugihara, Eiichi Tanaka, Takeo Nakayama, Masayoshi Harigai

Summary: This study examined the risk factors of surgical site infection, delayed wound healing, and death after orthopedic surgery in patients with rheumatoid arthritis. The use of biological disease modifying antirheumatic drugs was identified as a risk factor for surgical site infection, while rheumatoid arthritis itself, oral glucocorticoid use, age, male sex, comorbidities such as diabetes mellitus and chronic obstructive pulmonary disease, surgical factors, and longer operative time were all found to be risk factors for postoperative complications. Patients with these factors should be carefully monitored to ensure a balance between risks and benefits of orthopedic surgeries.

MODERN RHEUMATOLOGY (2022)

Article Nanoscience & Nanotechnology

Role of necroptosis of alveolar macrophages in acute lung inflammation of mice exposed to titanium dioxide nanoparticles

Tomoya Sagawa, Akiko Honda, Raga Ishikawa, Natsuko Miyasaka, Megumi Nagao, Sakiko Akaji, Takashi Kida, Takahiro Tsujikawa, Tatsushi Yoshida, Yutaka Kawahito, Hirohisa Takano

Summary: The study showed that exposure to titanium dioxide nanoparticles induced leukocyte migration into the alveolar region and increased secretion of C-C motif ligand (CCL) 3 in bronchoalveolar lavage (BAL) fluid. Macrophages in the lungs phagocytosed the TiO2 nanoparticles and underwent necroptosis, resulting in the translocation of high mobility group box-1 from the cell nucleus to the cytoplasm. Necroptosis of the phagocytosing macrophages was found to be involved in the mechanism by which titanium dioxide induces acute lung inflammation.

NANOTOXICOLOGY (2021)

Article Multidisciplinary Sciences

Patient satisfaction, preferences, expectations, characteristics, and impact of suboptimal control of rheumatoid arthritis: A subgroup analysis of Japanese patients from a large international cohort study (SENSE)

Yutaka Kawahito, Yuya Takakubo, Akio Morinobu, Naoko Matsubara, Orsolya Nagy, Eiji Sugiyama

Summary: Although most Japanese patients with RA with moderate-to-high disease activity were dissatisfied with their current DMARD treatment, high treatment adherence, high acceptability of combination therapy, high acceptability of manageable potential side effects, and preference for oral medication were reported. Data support the development of a more individualized and patient-centric approach for RA treatment.

PLOS ONE (2021)

Article Rheumatology

Drug treatment algorithm and recommendations from the 2020 update of the Japan College of Rheumatology clinical practice guidelines for the management of rheumatoid arthritis-secondary publication

Yutaka Kawahito, Akio Morinobu, Yuko Kaneko, Masataka Kohno, Shintaro Hirata, Mitsumasa Kishimoto, Yohei Seto, Takahiko Sugihara, Eiichi Tanaka, Hiromu Ito, Toshihisa Kojima, Isao Matsushita, Keiichiro Nishida, Masaaki Mori, Atsuko Murashima, Hisashi Yamanaka, Takeo Nakayama, Masayo Kojima, Masayoshi Harigai

Summary: The Japan College of Rheumatology has updated the clinical practice guidelines for rheumatoid arthritis, providing a useful tool for rheumatologists, healthcare professionals, and patients to make shared decisions in various clinical situations.

MODERN RHEUMATOLOGY (2023)

Article Infectious Diseases

Cervical lymphadenitis caused by Mycobacterium avium in a patient treated with Janus kinase inhibitors

Wataru Fujii, Liu Chang, Taka-aki Inui, Shigeyasu Ishizaka, Yutaka Kawahito

Summary: A female patient with rheumatoid arthritis treated with JAK inhibitors developed gradually enlarging bilateral submandibular lymph nodes swelling. Lymph node biopsy revealed granulomatous lymphadenitis with caseous necrosis, and Mycobacterium avium was identified. A CT scan showed no evidence of mass or infection elsewhere, and the mass was excised without antimicrobial treatment. No recurrence was observed 9 months after excision. Physicians should be aware of rare complications such as cervical lymphadenitis caused by nontuberculous mycobacteria when using JAK inhibitors.

INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES (2023)

Article Respiratory System

Identification and management of connective tissue disease-associated interstitial lung disease: evidence-based Japanese consensus statements

Masataka Kuwana, Masashi Bando, Yutaka Kawahito, Shinji Sato, Takafumi Suda, Yasuhiro Kondoh, CTD-ILD Delphi Collaborators

Summary: The study aimed to develop expert consensus statements and an algorithm for managing connective tissue disease-associated interstitial lung disease (CTD-ILD). Consensus was reached on important statements regarding screening, diagnosis and severity assessment, follow-up, and multidisciplinary management of CTD-ILD. An algorithm was developed based on these consensus statements.

EXPERT REVIEW OF RESPIRATORY MEDICINE (2023)

No Data Available